Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases
- 1 December 1989
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 45 (11-12) , 1108-1110
- https://doi.org/10.1007/bf01950171
Abstract
In a total of 62 samples of cerebrospinal fluid (CSF) and an equal number of serum samples obtained from 16 patients suffering from amyotrophic lateral sclerosis, 22 patients suffering from miscellaneous neurological diseases, and 24 controls, lead was measured by atomic absorption spectrophotometry. No statistical difference in lead concentration was found between the above three groups.This publication has 5 references indexed in Scilit:
- Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1983
- Further studies on the erythrocyte uptake of lead in vitro in amyotrophic lateral sclerosis (ALS) patients and controlsJournal of the Neurological Sciences, 1982
- Response to penicillamine of lead concentrations in CSF and blood in patients with motor neurone disease.BMJ, 1978
- Serum protein binding of lead in vitro in amyotrophic lateral sclerosis patients and controlsJournal of the Neurological Sciences, 1978
- Motor neurone disease and exposure to leadJournal of Neurology, Neurosurgery & Psychiatry, 1970